Why a Rs 12,000 vaccine isn’t the silver bullet against dengue in India

The same Aedes mosquitoes also transmit chikungunya and Zika, making integrated vector management indispensable. Eliminating mosquito breeding sites through better drainage and waste disposal must remain the first line of defence. . (Source: Getty Images/Thinkstock) 3 min readJul 29, 2026 05:32 PM IST First published on: Jul 29, 2026 at 05:32 PM IST India has taken an important step in the fight against dengue. On July 21, the Central Drugs Standard Control Organisation granted marketing authorisation to Qdenga, the country’s first approved dengue vaccine. Manufactured by Takeda GmbH, Germany, and marketed in India by Takeda Biopharmaceuticals, the vaccine has already been approved in 42 countries, including EU members, Indonesia, Thailand, Malaysia, Argentina and Brazil. More than 24 mill